Design and Validation of an Automated Process for the Expansion of Peripheral Blood‐Derived CD34+ Cells for Clinical Use After Myocardial Infarction

Design and Validation of an Automated Process for the Expansion of Peripheral Blood‐Derived CD34+ Cells for Clinical Use After Myocardial Infarction

Abstract We previously demonstrated that intracardiac delivery of autologous peripheral blood‐derived CD34+ stem cells (SCs), mobilized by granulocyte‐colony stimulating factor (G‐CSF) and collected by leukapheresis after myocardial infarction, structurally and functionally repaired the damaged myoc...

Full description

Bibliographic Details
Main Authors: Claire Saucourt, Sandrine Vogt, Amandine Merlin, Christophe Valat, Anthony Criquet, Laurence Harmand, Brigitte Birebent, Hélène Rouard, Christian Himmelspach, Éric Jeandidier, Anne‐Gaële Chartois‐Leauté, Sophie Derenne, Laurence Koehl, Joe‐Elie Salem, Jean‐Sébastien Hulot, Céline Tancredi, Anne Aries, Sébastien Judé, Eric Martel, Serge Richard, Luc Douay, Philippe Hénon
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Stem Cells Translational Medicine
Subjects:
CD34+
Cellular therapy
Hematopoietic stem cells
Peripheral blood stem cells
Cardiac
Cell culture
Online Access:https://doi.org/10.1002/sctm.17-0277

Internet

https://doi.org/10.1002/sctm.17-0277

Similar Items